Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Central Nervous System Neoplasms 6Neuroblastoma 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Brain Neoplasms 3Seminoma 2Pheochromocytoma 2Ovarian Neoplasms 2Medulloblastoma 2Glioma 2Endodermal Sinus Tumor 2Thrombocytopenia 1Teratoma 1Microphthalmia, Isolated, with Coloboma 5 1Lymphoma 1Intraocular Lymphoma 1Gliosarcoma 1Glioblastoma 1Dysgerminoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Embryonal 1

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Lapatinib 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × pegfilgrastim × CNS × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡